Nurbolat Bigeldiуev
Research Subjects
Research Interests
Nurbolat Bigeldiуev has a total of 13 co-authors. Here are the top co-authors by number of shared publications:
- Adil Baimbetov
Department of Interventional Cardiology, Arrhythmology and Endovascular Surgery, Syzganov National Scientific Center of Surgery, Almaty 050004, Kazakhstan
2 shared publications - Kenzhebek Bizhanov
JSC «National Scientific Center of Surgery named after A. N. Syzganov
2 shared publications - A.M. Jukenova1 shared publication
- Akmoldir Sarsenbayeva
Department of Interventional Cardiology, Arrhythmology and Endovascular Surgery, Syzganov National Scientific Center of Surgery, Almaty 050004, Kazakhstan
1 shared publication - Alexander Sapunov
Department of Interventional Cardiology, Arrhythmology and Endovascular Surgery, Syzganov National Scientific Center of Surgery, Almaty 050004, Kazakhstan
1 shared publication - Aliya Ualiyeva
Al-Farabi Kazakh National University, Almaty, Kazakhstan
1 shared publication
Latest Publications
- 1 October 2024
- Published by National Scientific Center of Surgery named after A.N. Syzganov in BULLETIN OF SURGERY IN KAZAKHSTAN
- Vol. 20 (3) , 82-90
THE INFLUENCE OF PULMONARY VEIN ANATOMY ON OUTCOMES AFTER ABLATION OF PAROXYSMAL ATRIAL FIBRILLATION
Background. Pulmonary vein isolation is the cornerstone of catheter-based treatment for atrial fibrillation. Cryoballoon ablation offers an effective and reproducible method for pulmonary vein isolation, yet recurrence of arrhythmias remains a challenge. Despite advances in catheter technologies, the role of altered pulmonary vein anatomy as a factor for atrial fibrillation recurrence is poorly studied. Materials and Methods. This prospective study included 465 patients with paroxysmal atrial fibrillation who underwent cryoballoon ablation. Pulmonary vein and left atrial anatomy were evaluated using multislice computed tomography. Patients were followed for 24–48 months to assess atrial fibrillation recurrence and anatomical risk factors. Cox proportional hazard modeling and Kaplan-Meier analysis were used to evaluate predictors of arrhythmia recurrence. Results. Complete Pulmonary vein isolation was achieved in all patients. During follow-up, 38% of patients experienced atrial fibrillation recurrence. Patients with altered pulmonary vein anatomy, particularly a left common pulmonary vein and additional pulmonary veins, showed a higher rate of recurrence. Cox regression analysis identified left atrial volume index >50 mL/m² and pathological pulmonary vein anatomy as independent risk factors for atrial fibrillation recurrence. Conclusion. Altered pulmonary vein anatomy is a significant risk factor for atrial fibrillation recurrence following cryoballoon ablation. Comprehensive imaging of the left atrial and pulmonary vein using multislice computed tomography can improve patient selection, reducing the recurrence risk and improving long-term outcomes.
- 1 October 2024
- Published by National Scientific Center of Surgery named after A.N. Syzganov in BULLETIN OF SURGERY IN KAZAKHSTAN
- Vol. 20 (3) , 82-90
THE INFLUENCE OF PULMONARY VEIN ANATOMY ON OUTCOMES AFTER ABLATION OF PAROXYSMAL ATRIAL FIBRILLATION
Background. Pulmonary vein isolation is the cornerstone of catheter-based treatment for atrial fibrillation. Cryoballoon ablation offers an effective and reproducible method for pulmonary vein isolation, yet recurrence of arrhythmias remains a challenge. Despite advances in catheter technologies, the role of altered pulmonary vein anatomy as a factor for atrial fibrillation recurrence is poorly studied. Materials and Methods. This prospective study included 465 patients with paroxysmal atrial fibrillation who underwent cryoballoon ablation. Pulmonary vein and left atrial anatomy were evaluated using multislice computed tomography. Patients were followed for 24–48 months to assess atrial fibrillation recurrence and anatomical risk factors. Cox proportional hazard modeling and Kaplan-Meier analysis were used to evaluate predictors of arrhythmia recurrence. Results. Complete Pulmonary vein isolation was achieved in all patients. During follow-up, 38% of patients experienced atrial fibrillation recurrence. Patients with altered pulmonary vein anatomy, particularly a left common pulmonary vein and additional pulmonary veins, showed a higher rate of recurrence. Cox regression analysis identified left atrial volume index >50 mL/m² and pathological pulmonary vein anatomy as independent risk factors for atrial fibrillation recurrence. Conclusion. Altered pulmonary vein anatomy is a significant risk factor for atrial fibrillation recurrence following cryoballoon ablation. Comprehensive imaging of the left atrial and pulmonary vein using multislice computed tomography can improve patient selection, reducing the recurrence risk and improving long-term outcomes.
- 1 July 2021
- Published by National Scientific Center of Surgery named after A.N. Syzganov in BULLETIN OF SURGERY IN KAZAKHSTAN
- No. III 2021,p. 51-58
HEART RATE CONTROL USING IMPLANTABLE DEVICES. WHAT WE HAVE ACHIEVED AND WHAT ELSE IS WAITING IN MODERN ARHYTHMOLOGY? REVIEW.
Ambulatory cardiac monitoring is a rapidly expanding field of functional diagnostics. Today, the main direction of cardiac monitoring is outpatient monitoring of the electrocardiogram, an important diagnostic tool that is used daily by doctors in many specialties. Therefore, both wearable and subcutaneous technologies of electrocardiographic monitoring are now widely used. A number of devices can be placed under the patient’s skin and have the ability to wirelessly transmit data to home transmitters, which, in turn, then transmit data to the doctor via cloud interfaces, so that, they allow remote monitoring and monitoring of the patient’s condition. Such systems are widely used in various countries of the world, approved in the USA, and are also used for remote monitoring of patients in Europe and Kazakhstan, where their implementation is gaining momentum. This review presents the technical aspects of subcutaneous monitoring, provides a schematic representation of the operation of systems existing on the market, discusses the advantages of this method, as well as the disadvantages of existing implantable cardiac monitors. The issues of the future development of this technology and indications for the use of existing devices approved by the professional cardiological communities are considered.
- 1 July 2021
- Published by National Scientific Center of Surgery named after A.N. Syzganov in BULLETIN OF SURGERY IN KAZAKHSTAN
- No. III 2021,p. 51-58
HEART RATE CONTROL USING IMPLANTABLE DEVICES. WHAT WE HAVE ACHIEVED AND WHAT ELSE IS WAITING IN MODERN ARHYTHMOLOGY? REVIEW.
Ambulatory cardiac monitoring is a rapidly expanding field of functional diagnostics. Today, the main direction of cardiac monitoring is outpatient monitoring of the electrocardiogram, an important diagnostic tool that is used daily by doctors in many specialties. Therefore, both wearable and subcutaneous technologies of electrocardiographic monitoring are now widely used. A number of devices can be placed under the patient’s skin and have the ability to wirelessly transmit data to home transmitters, which, in turn, then transmit data to the doctor via cloud interfaces, so that, they allow remote monitoring and monitoring of the patient’s condition. Such systems are widely used in various countries of the world, approved in the USA, and are also used for remote monitoring of patients in Europe and Kazakhstan, where their implementation is gaining momentum. This review presents the technical aspects of subcutaneous monitoring, provides a schematic representation of the operation of systems existing on the market, discusses the advantages of this method, as well as the disadvantages of existing implantable cardiac monitors. The issues of the future development of this technology and indications for the use of existing devices approved by the professional cardiological communities are considered.